PL324340A1 - Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids - Google Patents
Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acidsInfo
- Publication number
- PL324340A1 PL324340A1 PL96324340A PL32434096A PL324340A1 PL 324340 A1 PL324340 A1 PL 324340A1 PL 96324340 A PL96324340 A PL 96324340A PL 32434096 A PL32434096 A PL 32434096A PL 324340 A1 PL324340 A1 PL 324340A1
- Authority
- PL
- Poland
- Prior art keywords
- quinoxalinophosphonic
- quinoxalinoalkanophosphonic
- acids
- novel
- quinoxalinoalkanophosphonic acids
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH200995 | 1995-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL324340A1 true PL324340A1 (en) | 1998-05-25 |
Family
ID=4223780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96324340A PL324340A1 (en) | 1995-07-10 | 1996-07-01 | Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0837864A1 (en) |
| JP (1) | JPH11508902A (en) |
| KR (1) | KR19990028839A (en) |
| AU (1) | AU6516296A (en) |
| BR (1) | BR9609644A (en) |
| CA (1) | CA2224718A1 (en) |
| CZ (1) | CZ5398A3 (en) |
| HU (1) | HUP9901345A3 (en) |
| IL (1) | IL122872A0 (en) |
| NO (1) | NO980095L (en) |
| PL (1) | PL324340A1 (en) |
| SK (1) | SK2798A3 (en) |
| TR (1) | TR199800022T1 (en) |
| WO (1) | WO1997003079A1 (en) |
| ZA (1) | ZA965800B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ141399A3 (en) * | 1996-10-24 | 1999-07-14 | Novartis Ag | Substituted aminoalkanephosphonic acids, process of their preparation and pharmaceutical compositions containing thereof |
| US6841684B2 (en) | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
| US6329369B1 (en) | 1997-12-04 | 2001-12-11 | Allergan Sales, Inc. | Methods of treating pain and other conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118675A (en) * | 1991-02-15 | 1992-06-02 | American Home Products Corporation | Quinoxaline phosphono-amino acids |
| IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1996
- 1996-07-01 EP EP96924829A patent/EP0837864A1/en not_active Withdrawn
- 1996-07-01 HU HU9901345A patent/HUP9901345A3/en unknown
- 1996-07-01 KR KR1019980700140A patent/KR19990028839A/en not_active Withdrawn
- 1996-07-01 JP JP9505465A patent/JPH11508902A/en active Pending
- 1996-07-01 SK SK27-98A patent/SK2798A3/en unknown
- 1996-07-01 WO PCT/EP1996/002866 patent/WO1997003079A1/en not_active Ceased
- 1996-07-01 BR BR9609644A patent/BR9609644A/en not_active Application Discontinuation
- 1996-07-01 IL IL12287296A patent/IL122872A0/en unknown
- 1996-07-01 PL PL96324340A patent/PL324340A1/en unknown
- 1996-07-01 CZ CZ9853A patent/CZ5398A3/en unknown
- 1996-07-01 TR TR1998/00022T patent/TR199800022T1/en unknown
- 1996-07-01 AU AU65162/96A patent/AU6516296A/en not_active Abandoned
- 1996-07-01 CA CA002224718A patent/CA2224718A1/en not_active Abandoned
- 1996-07-09 ZA ZA965800A patent/ZA965800B/en unknown
-
1998
- 1998-01-09 NO NO980095A patent/NO980095L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122872A0 (en) | 1998-08-16 |
| CZ5398A3 (en) | 1998-06-17 |
| CA2224718A1 (en) | 1997-01-30 |
| NO980095D0 (en) | 1998-01-09 |
| WO1997003079A1 (en) | 1997-01-30 |
| ZA965800B (en) | 1997-01-10 |
| BR9609644A (en) | 1999-05-11 |
| MX9800332A (en) | 1998-07-31 |
| NO980095L (en) | 1998-03-05 |
| SK2798A3 (en) | 1998-07-08 |
| AU6516296A (en) | 1997-02-10 |
| HUP9901345A2 (en) | 1999-08-30 |
| JPH11508902A (en) | 1999-08-03 |
| TR199800022T1 (en) | 1998-05-21 |
| KR19990028839A (en) | 1999-04-15 |
| EP0837864A1 (en) | 1998-04-29 |
| HUP9901345A3 (en) | 2000-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL122428A0 (en) | Minizymes and minribozymes and uses thereof | |
| PL338357A1 (en) | Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives | |
| IL122392A0 (en) | Structurally determined metallo-constructs and applications | |
| AU6490396A (en) | Substituted-pent-4-ynoic acids | |
| EP0851759A4 (en) | Compounds and methods | |
| GB9325558D0 (en) | Percaboxylic acids | |
| ZA962768B (en) | Benzonitriles and benzofluorides | |
| IL113384A0 (en) | Alpha-aminolakanoic acids and reduction products | |
| EP0801644A4 (en) | Polyarylcarbamoylaza -and- carbamoylalkanedioic acids | |
| ZA952008B (en) | 5-vinyl- and 5-ethinyl-quinolene- and -naphthyridone- carboxylic acids | |
| GB9510830D0 (en) | Proteins | |
| PL332553A1 (en) | 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids | |
| EP0836617A4 (en) | Parevins and tachytegrins | |
| GB9516309D0 (en) | Novel compounds and process | |
| ZA968451B (en) | Novel sulfonylaminopyrimidines | |
| ZA964862B (en) | Optimized minizymes and miniribozymes and uses thereof | |
| SI1043332T1 (en) | Dipeptides comprising cyclopentan-beta-amino acids | |
| GB9423372D0 (en) | Proteins and their uses | |
| HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
| AU5188296A (en) | Carbopeptoids and carbonucleotoids | |
| IL120903A0 (en) | Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones their preparation and their uses | |
| HUP9901345A3 (en) | Novel quinoxaline- and quinoxalinylalkane-phosphonic acids | |
| GB9525234D0 (en) | Process compound and use | |
| GB9504876D0 (en) | Compounds and process | |
| ZA959512B (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas |